Ozempic Injection Sites: What the FDA Label Says

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This guide sits inside the PlexusDx Education Hub, where GLP-1 pharmacology, metabolic health, and the genetics beneath both are explained in plain language. Open the full Peptides & GLP-1 library.

Ozempic is given as a subcutaneous injection, and the FDA-approved label is specific about where those injections go, how to rotate them, and what to avoid. This page reports that labeled guidance and describes what a prescribing provider walks you through at the start of therapy — it is a factual summary, not a substitute for that in-person training.

What the label says about sites

Per the FDA-approved prescribing information for Ozempic, subcutaneous injections go into the abdomen, thigh, or upper arm. Each dose must land in subcutaneous tissue — the fat layer just beneath the skin — never into muscle and never intravenously. When used correctly according to the patient instructions-for-use booklet packaged with every pen, the injection device is designed to deliver the dose at a fixed depth, which takes a lot of the guesswork out of technique.

How rotation works

The label directs rotating sites within an anatomical area — for instance, moving around within the abdomen from one weekly dose to the next — to reduce localized skin reactions. Broken, tender, red, bruised, scarred, or hardened skin should be avoided, and the same exact spot should not be used on consecutive doses. Rotation technique is one of the first things a prescribing provider covers when therapy begins.

What the label specifically rules out

Ozempic is for subcutaneous use only — not intramuscular, not intravenous. Do not inject into an IV access line, do not inject through clothing, and do not share injection pens, given the cross-contamination risk. Do not mix it with another injectable in the same syringe unless a prescribing provider has specifically directed it. If a pen looks damaged, the solution is cloudy or discolored, or the pen has been exposed to extreme temperature, it should not be used.

When a site reaction needs a provider

Mild redness, itching, or a small raised area at the injection site is common and usually settles within hours to a day. Reach out to a prescribing provider for persistent or spreading redness or warmth, a lump that will not resolve, bleeding that will not stop, signs of infection such as fever or worsening tenderness or pus, or any allergic reaction — widespread rash, facial or throat swelling, difficulty breathing. A severe allergic reaction is an emergency.

Where genetics enters the picture

Injection sites are a technique question, but the biology that governs how your body responds to the therapy itself is inherited and upstream. Variants in FTO, GLP1R, and MC4R shape appetite, satiety, and energy balance long before a pen is uncapped. The PlexusDx Precision Peptide Genetic Test reads 14 pathways, 49 peptides, 150+ genetic insights across those traits, never predicting drug response and never forecasting how you will respond. Provider consultation within the Weight Management Protocols — including Tirzepatide Injection — covers technique, pen handling, and storage.

Storage and pen handling per the label

Site selection is only one part of the labeled handling instructions. The patient instructions-for-use booklet packaged with every pen also covers storage — including temperature considerations — and the checks to perform before each dose. If a pen appears damaged, if the solution is cloudy or discolored, or if the device has been exposed to extreme temperature, the label directs not using it. Pens are not shared between people, given the cross-contamination risk, and the product is not mixed with another injectable in the same syringe unless a provider specifically directs it. These handling details are as much a part of correct use as where the needle goes, and a prescribing provider reviews them at the start of therapy.

Frequently Asked Questions

Where should I inject Ozempic?

Per the FDA-approved prescribing information, it is injected subcutaneously into the abdomen, thigh, or upper arm, rotating within an anatomical area each week. Avoid broken, tender, bruised, scarred, or hardened skin. Your prescribing provider covers technique at the start of therapy and should answer any site-specific questions you have.

Can I use the same spot each week?

No. The FDA label directs rotating sites within an anatomical area to reduce localized skin reactions, so the exact same spot should not be used on consecutive doses. Moving around within the abdomen, or alternating between thigh and abdomen, is acceptable per the label. Ask your provider for specific rotation guidance.

What if I see bleeding after injecting?

A small amount of bleeding or mild bruising can happen and usually stops quickly with brief pressure. If bleeding does not stop, a large bruise forms, or you feel unwell afterward, contact your prescribing provider. The injection is subcutaneous by design, not intravascular, though small vessels can occasionally be affected.

Does the choice of site change results?

All three labeled sites — abdomen, thigh, and upper arm — are acceptable subcutaneous locations. Absorption varies modestly between sites in clinical pharmacology studies, but real-world outcomes are driven far more by consistent weekly dosing and proper rotation than by which site you pick. Follow your provider's guidance for your situation.

Keep exploring the evidence base inside the PlexusDx Education Hub.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.